RecruitingNot applicableNCT01851642

Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs

Studying Alpha-1-antitrypsin deficiency

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: University of Florida
Principal Investigator: Karina Serban, MD
University of Florida, College of Medicine, Division of Pulmonary, Critical Care, and Sleep Medicine
Intervention: History and physical exam.(procedure)
Enrollment: 220 enrolled
Eligibility: 18 years · All sexes
Timeline: 2007 – 2032

Study locations (1)

Shands at the University of Florida, Gainesville, Florida, United States

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01851642 on ClinicalTrials.gov

Other trials for Alpha-1-antitrypsin deficiency

Additional recruiting or active studies for the same condition.

See all trials for Alpha-1-antitrypsin deficiency →

← Back to all trials